Cargando…
Anti-Apo B-100 Autoantibody is a Marker of Unstable Coronary Plaque
Aims: Cardiovascular diseases (CVD) are a global leading cause of mortality. However, few biomarkers are available to predict future coronary plaque rupture. We have recently demonstrated that low levels of anti-apolipoprotein B-100 autoantibody (anti-apo B-100 Ab) correlated with an increased CVD r...
Autores principales: | Imai, Minami, Kawamura, Mari, Kochi, Ikoi, Matsuoka, Tetsuro, Kihara, Shinji, Yamamoto, Hiroyasu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Japan Atherosclerosis Society
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8560848/ https://www.ncbi.nlm.nih.gov/pubmed/33191364 http://dx.doi.org/10.5551/jat.58784 |
Ejemplares similares
-
Serum Anti-Apo B Antibody Level as Residual CVD Marker in DM Patients under Statin Treatment
por: Yamamoto, Hiroyasu, et al.
Publicado: (2019) -
Autoantibodies Against ApoB-100 as a New Marker of Coronary Vulnerable Plaque
por: Egusa, Genshi
Publicado: (2021) -
Cystatin C–Adiponectin Complex in Plasma Associates with Coronary Plaque Instability
por: Matsumoto, Akane, et al.
Publicado: (2017) -
Uptake of (68)gallium in atherosclerotic plaques in LDLR(-/-)ApoB(100/100 )mice
por: Silvola, Johanna MU, et al.
Publicado: (2011) -
Utility of mass spectrometry for the diagnosis of the unstable coronary plaque
por: Jacob, Shana S, et al.
Publicado: (2015)